Skip to main content
. 2018 Aug 29;19(9):2565. doi: 10.3390/ijms19092565
TME Tumor microenvironment
TAMC Tumor-associated myeloid cell
M/PMN/eMDSC Monocytic/polymorphonuclear/early-stage–myeloid-derived suppressor cell
UPR Unfolded protein response
CHOP C/EBP homologous protein
XBP1 X-box binding protein 1
IRE1α Inositol-requiring enzyme
MMP Matrix metalloproteinase
VEGFR2 Vascular endothelial growth factor receptor2
CD31 Platelet endothelial cell adhesion molecule1
TIE2 Tyrosine kinase with immunoglobulin and EGF-like domains
VEGF Vascular endothelial growth factor
FGF Fibroblast growth factor
ANG2 Angiopoietin 2
CXCL12 C-X-C motif chemokine 12
SDF-1α Stromal derived factor-1α
EC Endothelial cell
TEM TIE2-expressing macrophage
EPC Endothelial progenitor cell
AAT Antiangiogenic therapy